Seòmar agus comataidhean

As of 31st January 2022, 54,726 women in Scotland have waited more than 36 months since their last breast screen. Data presented in relation to S6W-06127 on 28 February 2022 sets out the average length of time between screening appointments by screening centre. Historically, the Scottish Breast screening Programme has invited around 260,000 women per year. In 2019-20 just under 270,000 women were invited.

The programme continues to recover from the March 2020 Covid-19 related pause, and the National Screening Oversight, Scottish Screening Committee and Breast Screening Programme Board (BSPB) continue to work with health boards to increase the number of available appointments, including through deploying additional mobile breast screening units and providing additional appointments during evenings and at weekends.

It should be noted that the data provided is management information that has not been subject to quality checks applied on an official publication.

All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

Since agreement of phased funding, SAS have been actively recruiting staff at pace and increasing vehicles on the ground on a transition basis into priority locations across the country. Seven additional satellite stations have already been established, with a further three still to be established, enabling resources to be spread across busy urban areas to better match patient demand.

Alongside this, the service having been working in partnership to design new rosters. SAS are expecting new rosters to be implemented in April 2022 for the majority of locations across the East and North Regions. The West Region full implementation is expected to be concluded by the end of July.

Recruitment for phase 3 of the review has commenced and will enable SAS to increase their establishment by a further 162 staff as well as further increase our station locations and vehicles on the ground.

The Service commissioned an independent Demand and Capacity Review in 2017. Funding has since been approved on a phased basis, with the third phase of the review scheduled to be concluded and changes implemented by November 2022.

The Scottish Ambulance Service continues to provide data each year to Operational Research in Health (ORH) to continually update the model. This enables resourcing requirements to be modelled each year to take account of changes in the data and wider health and social care system, therefore the most recent modelling includes the impact of COVID 19.

I refer the member to the answer to question S6W-06307 on 28 February 2022. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

The pandemic paused the Oral Health Improvement Programme, which was developing, through Design Groups, preventive and patient focused care through the New Model of Care.

The clear focus for Scottish Government is to recover and stabilise NHS dental services, enabling the sector to emerge from the pandemic in a condition to improve patient access to care. The recovery of the sector will support the development of the longer term reform programme, building back the sector to support necessary strategic reforms that develop the work that was developed in the Design Groups pre-pandemic.

Scottish Government has signalled some key areas for the reform programme through fee changes that were put in place form 1 February, in particular the preventive Childsmile element, focus on deprivation and harmonisation of examination fees for adult and child patients.

The Scottish Government acted on requests by retail organisations not to launch the consultation in the run-up to Christmas which is the busiest trading period and may not have allowed retailers the full opportunity to share their views. We took the opportunity to liaise with a short-life working group and update the consultation in line with the most recent emerging evidence.

People with certain neuromuscular conditions, such as motor neurone disease and multiple sclerosis, are eligible for antiviral medication The eligibility criteria for direct access to new COVID-19 treatments were developed by an independent expert working group commissioned by the UK Department of Health and Social Care and is based on detailed clinical evidence. The criteria are set out in a UK-wide clinical commissioning policy . The policy targets those higher risk individuals who have the potential to both be least likely to generate a material immune response to vaccines and be at highest risk of disease progression, hospitalisation and death.

Further information is available on NHS Inform .

In addition to the direct access arrangements described above for the most vulnerable, coronavirus oral antiviral treatments are being evaluated through a UK-wide study called PANORAMIC, run by the University of Oxford. Full details about the eligibility criteria for the study can be found at: https://www.panoramictrial.org/

The outcomes from the study will enable the NHS to fully understand how best to make use of these treatments in the future.

The information requested is not held centrally. However, patients are asked to contact their local Health Board single point of contact telephone number if they believe they are eligible for treatment. The phone lines are open seven days a week, including public holidays. Further information is available on NHS Inform .

Some COVID-19 positive individuals who meet the eligibility criteria will decide not to receive antiviral treatments, or may be unable to, for example due to other medications they are taking.

Internationally renowned modelling company Operational Research in Health (ORH) were commissioned by the Scottish Ambulance Service to carry out an analysis on 7 years’ worth of data to help inform the review of demand and capacity.

ORH used a population growth data to predict future demand and resources required to meet performance standards. This included patient demand, types of clinical presentation, on scene times, at hospital times, travel times, vehicle tracking data, resourcing levels, receiving hospitals, station locations, rest periods and standard operating procedures.

In addition, Working Time Solutions were also commissioned to assist with the design and implementation of rosters that better match demand profiles.

Following approval, SAS will publish the third phase of the business case.